Inhibition of the B cell associated tyrosine kinase SYK as a potential therapeutic target in aggressive lymphomas.

被引：0
|
作者：
Bertoni, F
Ridaidi, A
Sasso, A
Uccella, S
Martin, V
Napoli, S
Pruneri, G
Zucca, E
Capella, C
Catapano, CV
Tibiletti, MG
Cavalli, F
机构：
[1] Oncol Inst Sos Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[2] Oncol Inst Sos Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[3] Univ Insubria, Osped Circolo, Anat Pathol Unit, Varese, Italy
[4] European Inst Oncol, Div Pathol & Lab Med, Milan, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1469
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 50 条
  • [1] Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
    Qu, Chen
    Zheng, Dandan
    Li, Sai
    Lidofsky, Anna
    Jiang, Yuchuan
    He, Lu
    Yuan, Hui
    Chen, Xijun
    Hu, Qiaoting
    Luo, Xiaojun
    Zhou, Yuchen
    Lin, Wenyu
    Chung, Raymond T.
    Hong, Jian
    HEPATOLOGY, 2017, 66 : 136A - 137A
  • [2] Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
    Qu, Chen
    Zheng, Dandan
    Li, Sai
    Liu, Yingjun
    Lidofsky, Anna
    Holmes, Jacinta A.
    Chen, Jianning
    He, Lu
    Wei, Lan
    Liao, Yadi
    Yuan, Hui
    Jin, Qimeng
    Lin, Zelong
    Hu, Qiaoting
    Jiang, Yuchuan
    Tu, Mengxian
    Chen, Xijun
    Li, Weiming
    Lin, Wenyu
    Fuchs, Bryan C.
    Chung, Raymond T.
    Hong, Jian
    HEPATOLOGY, 2018, 68 (03) : 1125 - 1139
  • [3] Syk tyrosine kinase is overexpressed in the majority of peripheral T- and NK-cell lymphomas, and represents a potential therapeutic target.
    Feldman, Andrew L.
    Sun, David X.
    Law, Mark E.
    Novak, Anne J.
    Attygalle, Ayoma D.
    Thorland, Erik C.
    Fink, Stephanie R.
    Vrana, Julie A.
    Caron, B. Lynn
    Morice, William G.
    Remstein, Ellen D.
    Grogg, Karen L.
    Kurtin, Paul J.
    Macon, William R.
    Dogan, Ahmet
    BLOOD, 2007, 110 (11) : 212A - 212A
  • [4] Inhibition of NFκB activation as a possible therapeutic target in human leukemias and lymphomas.
    Liu, RY
    Fan, C
    Li, XC
    Whitehouse, B
    Zuckerman, KS
    BLOOD, 2001, 98 (11) : 324A - 325A
  • [5] Getting Syk: spleen tyrosine kinase as a therapeutic target
    Geahlen, Robert L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (08) : 414 - 422
  • [6] Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
    Rinaldi, A
    Kwee, I
    Taborelli, M
    Largo, C
    Uccella, S
    Martin, V
    Poretti, G
    Gaidano, G
    Calabrese, G
    Martinelli, G
    Baldini, L
    Pruneri, G
    Capella, C
    Zucca, E
    Cotter, FE
    Cigudosa, JC
    Catapano, CV
    Tibiletti, MG
    Bertoni, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) : 303 - 316
  • [7] Grey zone lymphomas. Limitations of the classification of aggressive B-cell lymphomas
    Ott, M. M.
    Horn, H.
    Rosenwald, A.
    Ott, G.
    PATHOLOGE, 2013, 34 (03): : 225 - 232
  • [8] Spleen Tyrosine Kinase (SYK) Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    BLOOD, 2008, 112 (11) : 203 - 203
  • [9] Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
    Feldman, A. L.
    Sun, D. X.
    Law, M. E.
    Novak, A. J.
    Attygalle, A. D.
    Thorland, E. C.
    Fink, S. R.
    Vrana, J. A.
    Caron, B. L.
    Morice, W. G.
    Remstein, E. D.
    Grogg, K. L.
    Kurtin, P. J.
    Macon, W. R.
    Dogan, A.
    LEUKEMIA, 2008, 22 (06) : 1139 - 1143
  • [10] Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
    A L Feldman
    D X Sun
    M E Law
    A J Novak
    A D Attygalle
    E C Thorland
    S R Fink
    J A Vrana
    B L Caron
    W G Morice
    E D Remstein
    K L Grogg
    P J Kurtin
    W R Macon
    A Dogan
    Leukemia, 2008, 22 : 1139 - 1143
12345